EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tail-less precursors in synthetic cannabinoid production: investigating a clandestine laboratory, seized samples, and CB1 activity

Manuela Carla Monti iD, Tobias Rautio iD, Marie H Deventer iD, Markus Schläpfer, Johannes Tveit iD, Alex J Krotulski iD, Victoria Marland iD, Robert Reid iD, Niamh Nic Daeid iD, Craig McKenzie iD, Christophe P Stove iD, Henrik Green iD und 1 weitere

Archives of Toxicology · 2025-09 · 99 (9) · 3641-3661

DOI: 10.1007/s00204-025-04086-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Toxicology, online erschienen am 23.05.2025. Verfasst von Manuela Carla Monti und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Chemistry and Pharmacology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden. Hauptthemen laut MEDLINE: Cannabinoids, Receptor, Cannabinoid, CB1, Cannabinoid Receptor Agonists, Illicit Drugs. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Eurostars, VINNOVA, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An emerging new trend reveals that potent synthetic cannabinoid receptor agonists (SCRAs) that were prevalent prior to the Chinese class-wide ban in July 2021 have remained on the market or re-emerged. This is likely because of a new production route where unscheduled tail-less precursors are converted into the desired controlled SCRA via a one-step synthesis. This study reports the discovery of a clandestine production site in Switzerland for this synthesis. Controlled recreations of the synthesis of ADB-BUTINACA (also known as ADB-BINACA or ADMB-BUTINACA) and MDMB-4en-PINACA based on a recipe recovered from the Swiss production site were undertaken. The recreations yielded oils or waxy products with chromatographic purities ranging from 39.3 to 93.4% with the precursors (ADB-INACA or MDMB-INACA) remaining in all products. Mixtures of a precursor (e.g., MDMB-INACA, ADB-INACA, AB-INACA, MDMB-ICA, ADB-IATA, MDMB-5’Me-INACA) with corresponding final SCRA(s) (e.g., MDMB-4en-PINACA, 4F-MDMB-BUTINACA, MDMB-BUTINACA, MDMB-FUBINACA, ADB-BUTINACA, ADB-4en-PINACA, AB-CHMINACA, 4F-MDMB-BUTICA, ADB-FUBIATA) were found in 28 forensic casework samples in the US received between February 2023 and February 2024 and 87 samples seized from the Scottish prisons between February 2023 and July 2024. In vitro CB 1 receptor activity of the precursors, synthesized products, and mixtures of precursors and final SCRAs were examined using β-arrestin 2 recruitment and intracellular calcium release assays. The precursors were much less potent than the final SCRAs and the concentration of the final SCRA dictated the activity of mixtures. This study raises awareness of the emergence of a new production method for SCRAs as observed in multiple countries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabinoidsReceptor, Cannabinoid, CB1Cannabinoid Receptor AgonistsIllicit DrugsHumansSwitzerlandAnimalsCHO CellsCricetulus

Stichwörter der Autor:innen

CB1 cannabinoid receptorClandestine drug laboratory investigationNew psychoactive substancesPrecursorsSynthetic cannabinoid receptor agonists

Substanzen

CannabinoidsReceptor, Cannabinoid, CB1Cannabinoid Receptor AgonistsIllicit Drugs

Autor:innen und Institutionen

  • Division of Clinical Chemistry and Pharmacology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Department of Physics, Chemistry and Biology, Linköping University, Linköping, Sweden.
  • Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.
  • Zurich Forensic Science Institute, Zurich, Switzerland.
  • Chiron AS, Trondheim, Norway.
  • Center for Forensic Science Research and Education, Fredric Rieders Family Foundation, Horsham, PA, USA.

ORCID-Profile: Manuela Carla Monti, Tobias Rautio, Marie H Deventer, Johannes Tveit, Alex J Krotulski, Victoria Marland, Robert Reid, Niamh Nic Daeid, Craig McKenzie, Christophe P Stove, Henrik Green, Caitlyn Norman

Förderung

  • Eurostars
  • VINNOVA
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Stichting Wetenschappelijk Onderzoek Oogziekenhuis
  • Scottish Prison Service
  • Leverhulme Trust
  • National Institute of Justice
  • Horizon 2020

Zitieren

APA

Monti, M. C., Rautio, T., Deventer, M. H., Schläpfer, M., Tveit, J., Krotulski, A. J., Marland, V., Reid, R., Daeid, N. N., McKenzie, C., Stove, C. P., Green, H., & Norman, C. (2025). Tail-less precursors in synthetic cannabinoid production: investigating a clandestine laboratory, seized samples, and CB1 activity. Archives of Toxicology, 99(9), 3641-3661. https://doi.org/10.1007/s00204-025-04086-0

Vancouver

Monti MC, Rautio T, Deventer MH, Schläpfer M, Tveit J, Krotulski AJ, et al. Tail-less precursors in synthetic cannabinoid production: investigating a clandestine laboratory, seized samples, and CB1 activity. Archives of Toxicology. 2025;99(9):3641-3661. doi:10.1007/s00204-025-04086-0

BibTeX
@article{Monti2025,
  author = {Monti, Manuela Carla and Rautio, Tobias and Deventer, Marie H and Schläpfer, Markus and Tveit, Johannes and Krotulski, Alex J and Marland, Victoria and Reid, Robert and Daeid, Niamh Nic and McKenzie, Craig and Stove, Christophe P and Green, Henrik and Norman, Caitlyn},
  title = {Tail-less precursors in synthetic cannabinoid production: investigating a clandestine laboratory, seized samples, and CB1 activity},
  journal = {Archives of Toxicology},
  year = {2025},
  volume = {99},
  number = {9},
  pages = {3641--3661},
  doi = {10.1007/s00204-025-04086-0}
}
Kostenlos starten →